
Chia Tai Enterprises International Limited (3839.HK)
3839.HK Stock Price Chart
Explore Chia Tai Enterprises International Limited interactive price chart. Choose custom timeframes to analyze 3839.HK price movements and trends.
3839.HK Company Profile
Discover essential business fundamentals and corporate details for Chia Tai Enterprises International Limited (3839.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
3 Jul 2015
Employees
900.00
Website
https://www.ctei.com.hkCEO
Thirayut Phityaisarakul
Description
Chia Tai Enterprises International Limited engages in the manufacture and sale of chlortetracycline (CTC) and other related products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment manufactures and sells CTC premix and CTC hydrochloride products, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brands. The Industrial segment engages in the sale, leasing, and servicing of caterpillar machinery equipment, including excavators, power generators, bulldozers, and compactors, as well as spare parts; and manufacture and sale of carburetors and automotive parts for automobile and motorcycle manufacturers. The company was incorporated in 1987 and is based in Central, Hong Kong. Chia Tai Enterprises International Limited is a subsidiary of Charoen Pokphand Foods Public Company Limited.
3839.HK Financial Timeline
Browse a chronological timeline of Chia Tai Enterprises International Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 23 Feb 2026
Upcoming earnings on 10 Nov 2025
Earnings released on 7 Aug 2025
Earnings released on 15 May 2025
Earnings released on 24 Feb 2025
EPS came in at $0.21 , while revenue for the quarter reached $1.07B .
Earnings released on 12 Nov 2024
EPS came in at $0.09 , while revenue for the quarter reached $2.39B .
Earnings released on 9 Aug 2024
EPS came in at $0.03 , while revenue for the quarter reached $416.47M .
Earnings released on 9 May 2024
EPS came in at $0.03 , while revenue for the quarter reached $427.66M .
Earnings released on 23 Feb 2024
EPS came in at $0.01 , while revenue for the quarter reached $409.62M .
Earnings released on 10 Nov 2023
EPS came in at $0.00 , while revenue for the quarter reached $303.02M .
Earnings released on 10 Aug 2023
EPS came in at $0.01 , while revenue for the quarter reached $308.00M .
Earnings released on 10 May 2023
EPS came in at $0.05 , while revenue for the quarter reached $341.46M .
Earnings released on 24 Feb 2023
EPS came in at -$0.06 , while revenue for the quarter reached $325.22M .
Earnings released on 31 Dec 2022
EPS came in at $0.01 , while revenue for the quarter reached $285.55M .
Earnings released on 30 Jun 2022
EPS came in at -$0.09 , while revenue for the quarter reached $330.23M .
Earnings released on 31 Mar 2022
EPS came in at -$0.06 , while revenue for the quarter reached $306.37M .
Earnings released on 31 Dec 2021
EPS came in at $0.06 , while revenue for the quarter reached $341.71M .
Earnings released on 30 Sept 2021
EPS came in at $0.33 , while revenue for the quarter reached $274.14M .
Earnings released on 30 Jun 2021
EPS came in at $0.05 , while revenue for the quarter reached $214.29M .
Earnings released on 31 Mar 2021
EPS came in at $0.16 , while revenue for the quarter reached $278.12M .
Earnings released on 31 Dec 2020
EPS came in at $0.07 , while revenue for the quarter reached $183.25M .
Earnings released on 31 Dec 2020
EPS came in at $0.12 , while revenue for the quarter reached $725.49M .
Earnings released on 31 Dec 2020
EPS came in at $0.12 , while revenue for the quarter reached $725.49M .
3839.HK Stock Performance
Access detailed 3839.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.